Considering the relationships between chronic hepatitis and SOCS proteins, small-molecule antagonists of SOCS signaling and SOCS protein silencing could be viable strategies for improving the treatment of chronic hepatitis as well as effectively mitigating hepatitis virus infection. The gene discussed is CISH; the disease is chronic hepatitis.